The pharmacologist

Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elgoyhen, A.B., Rothlin, C.V.
Formato: CHAP
Materias:
Animal models
Drug discovery
Lead compounds
Phantom sound
Tinnitus
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_97816076_v_n_p251_Elgoyhen
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires
id todo:paper_97816076_v_n_p251_Elgoyhen
record_format dspace
spelling todo:paper_97816076_v_n_p251_Elgoyhen2023-10-03T16:44:09Z The pharmacologist Elgoyhen, A.B. Rothlin, C.V. Animal models Drug discovery Lead compounds Phantom sound Tinnitus Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus. © Springer Science+Business Media, LLC 2011. CHAP info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_97816076_v_n_p251_Elgoyhen
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Animal models
Drug discovery
Lead compounds
Phantom sound
Tinnitus
spellingShingle Animal models
Drug discovery
Lead compounds
Phantom sound
Tinnitus
Elgoyhen, A.B.
Rothlin, C.V.
The pharmacologist
topic_facet Animal models
Drug discovery
Lead compounds
Phantom sound
Tinnitus
description Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus. © Springer Science+Business Media, LLC 2011.
format CHAP
author Elgoyhen, A.B.
Rothlin, C.V.
author_facet Elgoyhen, A.B.
Rothlin, C.V.
author_sort Elgoyhen, A.B.
title The pharmacologist
title_short The pharmacologist
title_full The pharmacologist
title_fullStr The pharmacologist
title_full_unstemmed The pharmacologist
title_sort pharmacologist
url http://hdl.handle.net/20.500.12110/paper_97816076_v_n_p251_Elgoyhen
work_keys_str_mv AT elgoyhenab thepharmacologist
AT rothlincv thepharmacologist
AT elgoyhenab pharmacologist
AT rothlincv pharmacologist
_version_ 1782025138949062656

Ejemplares similares